How Thinking Like a Tech Start Up Led to Strides Forward in NGLY1 Deficiency Research
Source: Pixabay

How Thinking Like a Tech Start Up Led to Strides Forward in NGLY1 Deficiency Research

Rare disease research can feel like an uphill battle. First of all, rare diseases have a harder time receiving funding. After that, it takes months or even years to have…

Continue Reading How Thinking Like a Tech Start Up Led to Strides Forward in NGLY1 Deficiency Research
French Scientists and Doctors are Leading the Way Towards a Cure for Sickle Cell Anemia
Source: www.pixabay.com

French Scientists and Doctors are Leading the Way Towards a Cure for Sickle Cell Anemia

Some breathtaking things are happening in the world of sickle cell anemia (SCA) that could potentially impact the lives of nearly 275,000 babies around the world and nearly 100,000 African…

Continue Reading French Scientists and Doctors are Leading the Way Towards a Cure for Sickle Cell Anemia

TOMORROW Watch the Multiple System Atrophy Coalition Patient & Family Conference LIVE on Facebook

Have Neurogenic Orthostatic Hypotension or other MSA? Join the LIVE FEED and Watch the annual MSA Patient & Family Conference on Facebook On October 13-14, the Multiple System Atrophy (MSA)…

Continue Reading TOMORROW Watch the Multiple System Atrophy Coalition Patient & Family Conference LIVE on Facebook
Scientists’ Slimey Discovery Could Yield More Effective Pneumonia Treatment for Cystic Fibrosis
aitoff / Pixabay

Scientists’ Slimey Discovery Could Yield More Effective Pneumonia Treatment for Cystic Fibrosis

Researchers at the at Indiana University-Purdue University Indianapolis are studying slime. That's right. And it's not just any slime. It's the slime produced by bacteria that keeps antibiotics from being…

Continue Reading Scientists’ Slimey Discovery Could Yield More Effective Pneumonia Treatment for Cystic Fibrosis

Safer, More Efficient CRISPR Tech Offers Possible Duchenne Muscular Dystrophy Treatment

We've written about CRISPR technology before, and it's potential for treating sickle cell anemia. But in a latest study done at the University of California, Berkeley, sponsored by the NIH,…

Continue Reading Safer, More Efficient CRISPR Tech Offers Possible Duchenne Muscular Dystrophy Treatment